(RTTNews) - Roche (RHHBY) announced CE label expansion of the VENTANA PD-L1 (SP263) Assay in non-small cell lung cancer or NSCLC as a companion diagnostic for Tecentriq (atezolizumab).

Comar, a leader in healthcare packaging, has achieved CE certification under the EU Medical Device Regulation (EU MDR 2017/745), reaffirming its commitment to regulatory excellence, patient safety ...